Molecular basis for improved anthrax vaccines
- 21 April 2005
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 57 (9), 1266-1292
- https://doi.org/10.1016/j.addr.2005.01.028
Abstract
No abstract availableThis publication has 188 references indexed in Scilit:
- Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccinationInternational Journal of Medical Microbiology, 2004
- The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaNature, 2003
- Anthrax inhalation and lethal human infectionThe Lancet, 2002
- Involvement of Residues 147VYYEIGK153 in Binding of Lethal Factor to Protective Antigen of Bacillus anthracisBiochemical and Biophysical Research Communications, 2001
- Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFαFEBS Letters, 1999
- AnthraxNew England Journal of Medicine, 1999
- Anthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine/threonine phosphorylation of MAPKS in cultured macrophagesJournal of Applied Microbiology, 1999
- Structure-Function Analysis of Bacillus anthracis Edema Factor by Using Monoclonal AntibodiesBiochemical and Biophysical Research Communications, 1994
- Location of receptor-binding region of protective antigen from BacillusanthracisBiochemical and Biophysical Research Communications, 1991
- Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracisGene, 1989